Bill > S0642

This bill amends Florida Statutes to establish new requirements for entities involved in the retail sale of ephedrine and related compounds. Beginning July 1, 2025, all covered entities (which likely refers to businesses selling these substances) must pay monthly fees to the administrator of an electronic recordkeeping system that tracks these sales. The administrator will determine the specific fee amounts for each entity. If requested, covered entities must provide written documentation to the Department of Law Enforcement proving they have paid these fees. Failure to pay the required fees will be considered a violation of the statute and can result in criminal penalties. The bill's effective date is contingent on the passage of related legislation (SB 640) during the same legislative session. The purpose appears to be maintaining a robust tracking system for the sale of substances that can be used to manufacture illegal drugs, with financial contributions from businesses to support the administrative infrastructure.

https://www.flsenate.gov/Session/Bill/2025/642